Long Focus Capital Management’s Cellectis CLLS Stock Holding History

Long Focus Capital Management’s Portfolio CLLS Stock Details CLLS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$8.23M	Sell	2,741,853 -2,245	-0.1%	-$7.98K	0.21%	65
2026 Q1	$8.7M	Sell	2,744,098 -43,652	-2%	-$167K	0.23%	71
2025 Q4	$13.5M	Sell	2,787,750 -1,335,512	-32%	-$5.58M	0.36%	60
2025 Q3	$11.8M	Sell	4,123,262 -594,031	-13%	-$1.54M	0.39%	58
2025 Q2	$7.12M	Hold	4,717,293	–	–	0.27%	69
2025 Q1	$5.85M	Buy	4,717,293 +100,000	+2%	+$148K	0.2%	71
2024 Q4	$8.31M	Hold	4,617,293	–	–	0.27%	59
2024 Q3	$9.88M	Hold	4,617,293	–	–	0.35%	46
2024 Q2	$8.63M	Buy	4,617,293 +130,000	+3%	+$341K	0.33%	44
2024 Q1	$11.9M	Hold	4,487,293	–	–	0.61%	35
2023 Q4	$13.8M	Hold	4,487,293	–	–	0.46%	26
2023 Q3	$7.09M	Hold	4,487,293	–	–	0.25%	47
2023 Q2	$8.84M	Hold	4,487,293	–	–	0.4%	34
2023 Q1	$8.66M	Buy	4,487,293 +1,803,660	+67%	+$4.52M	0.49%	35
2022 Q4	$5.64M	Hold	2,683,633	–	–	0.39%	48
2022 Q3	$6.15M	Sell	2,683,633 -107,977	-4%	-$327K	0.6%	34
2022 Q2	$7.9M	Buy	2,791,610 +249,251	+10%	+$878K	0.83%	24
2022 Q1	$11.5M	Buy	2,542,359 +1,386,013	+120%	+$7.63M	1.48%	16
2021 Q4	$9.39M	Buy	+1,156,346	New	+$11.4M	1.24%	15

Other funds holding CLLS

BGI

B Group Inc Dallas, Texas $213M AUM 96.05% 1-Year Est. Return

UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return

NAMI

Nomura Asset Management International Philadelphia, Pennsylvania $66.6B AUM

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

DRD

Dennis R. Delaney $314M AUM 35.76% 1-Year Est. Return

Long Focus Capital Management's CLLS Position: Q2 2026 in Review

Long Focus Capital Management reduced its Cellectis (CLLS) stake by 0.08% in Q2 2026, selling an estimated $7.98K and leaving 2,741,853 shares worth $8.23M. The position accounts for 0.21% of the portfolio, ranked #65.

Long Focus Capital Management first reported a position in CLLS in Q4 2021 and has held it in 19 quarters since. The position peaked at $13.8M in Q4 2023. 27 funds tracked by Wall St. Rank hold CLLS as of Q2 2026.

Long Focus Capital Management held 2,741,853 shares of Cellectis worth $8.23M as of Q2 2026.
Long Focus Capital Management sold 2,245 Cellectis shares in Q2 2026, an estimated $7.98K.
Cellectis made up 0.21% of Long Focus Capital Management's portfolio in Q2 2026, its #65 holding.
Long Focus Capital Management first reported a position in Cellectis in Q4 2021 and has held it in 19 quarters since.
Long Focus Capital Management's Cellectis position peaked at $13.8M in Q4 2023.
27 funds tracked by Wall St. Rank held Cellectis as of Q2 2026.

Based on Long Focus Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.